Issue of performance rights

NOTICE PURSUANT TO NZX MAIN BOARD LISTING RULE 7.12.1
In accordance with NZX Main Board Listing Rule 7.12.1, NZME Limited (Company) advises of the
relevant details of the unlisted performance rights it has issued.

Class of Security
Performance rights representing an entitlement to
acquire ordinary shares in the Company.
ISIN
Not applicable - the performance rights will not be
listed on ASX or NZX.
Number issued
815,540 performance rights.
Issue Price
Not applicable.
Payment in cash
Not applicable.
Amount paid up (if not in full)
Not applicable.
Percentage of the total class of securities issued:
100% of all performance rights granted under the
Company's Long-Term Incentive Plan.
Reason for issue:
The grant of performance rights is part of the on-
going long-term incentive arrangements that the
Company has adopted to assist in the reward,
retention and motivation of its employees and senior
management.
Specific authority for issue:
Board resolution pursuant to the NZX Listing Rules.
Terms or details of issue:
Each performance right is issued pursuant to the
terms and conditions of the Company's Long-Term
Incentive Plan.
The issue of performance rights are subject to the
satisfaction of financial and non-financial performance
conditions set at the beginning of each performance
period. The financial condition is achievement of
budget EBITDA during the performance period and this
applies to 75% of the opportunity to performance rights.
Non-financial conditions are set per executive and
apply to the remaining 25% of the opportunity.
Upon vesting, each performance right will entitle the
holder to one ordinary share in the Company.
Total number of securities of the class in existence
after the issue:
815,540 performance rights.
Treasury stock (acquisition only):
Not applicable.
Date of issue
23 February 2017

Allison Whitney
Legal Counsel and Company Secretary
NZME Limited

---

Appendix 3B
New issue announcement


100256102/5396902.1
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 1
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B

New issue announcement,
application for quotation of additional securities
and agreement

Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12,
04/03/13


Name of entity
NZME Limited

ABN
ARBN 612 823 864

We (the entity) give ASX the following information.


Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).

1
+
Class of
+
securities issued or to
be issued

Performance rights representing an
entitlement to acquire ordinary shares
(Performance Rights) in NZME Limited (the
Company).


2 Number of
+
securities issued or
to be issued (if known) or
maximum number which may
be issued

815,540

Appendix 3B
New issue announcement


100256102/5396902.1
+ See chapter 19 for defined terms.
Appendix 3B Page 2 04/03/2013
3 Principal terms of the
+
securities (e.g. if options,
exercise price and expiry date; if
partly paid
+
securities, the
amount outstanding and due
dates for payment; if
+
convertible securities, the
conversion price and dates for
conversion)
Each Performance Right is issued under the
Company’s Total Incentive Plan (the Plan).

Subject to the Plan and the letter of
invitation sent to each Performance Right
holder, it is expected that the Performance
Right holders will be able to exercise the
Performance Rights after 31 December 2019.

There is no consideration payable on the
exercise of the Performance Rights, and
when exercised each Performance Right
entitles the holder to receive one ordinary
share in the Company.

Appendix 3B
New issue announcement


100256102/5396902.1
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 3


4 Do the
+
securities rank equally
in all respects from the
+
issue
date with an existing
+
class of
quoted
+
securities?

If the additional
+
securities do
not rank equally, please state:
 the date from which they do
 the extent to which they
participate for the next
dividend, (in the case of a
trust, distribution) or
interest payment
 the extent to which they do
not rank equally, other than
in relation to the next
dividend, distribution or
interest payment
Prior to exercise, the Performance Rights do
not entitle the holder to vote or receive
dividends or distributions.

Any ordinary shares that are issued upon
the exercise of the Performance Rights will,
however, rank equally with the existing
ordinary shares on issue from the date of
their issue and allotment.


5 Issue price or consideration

Nil.


6 Purpose of the issue
(If issued as consideration for
the acquisition of assets, clearly
identify those assets)






The grant of Performance Rights is part of
the ongoing long term incentive
arrangements that the Company has
adopted to assist in the reward, retention
and motivation of its employees and senior
management.


6a Is the entity an
+
eligible entity
that has obtained security
holder approval under rule 7.1A?

If Yes, complete sections 6b – 6h
in relation to the
+
securities the
subject of this Appendix 3B, and
comply with section 6i
N/A


6b The date the security holder
resolution under rule 7.1A was
passed
N/A


6c Number of
+
securities issued
without security holder approval
under rule 7.1
N/A


6d Number of
+
securities issued
with security holder approval
under rule 7.1A
N/A

Appendix 3B
New issue announcement


100256102/5396902.1
+ See chapter 19 for defined terms.
Appendix 3B Page 4 04/03/2013


6e Number of
+
securities issued
with security holder approval
under rule 7.3, or another
specific security holder approval
(specify date of meeting)

N/A


6f Number of
+
securities issued
under an exception in rule 7.2
N/A


6g If
+
securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+
issue date and both values.
Include the source of the VWAP
calculation.
N/A


6h If
+
securities were issued under
rule 7.1A for non-cash
consideration, state date on
which valuation of
consideration was released to
ASX Market Announcements
N/A


6i Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements
N/A


7
+
Issue dates
Note: The issue date may be prescribed by
ASX (refer to the definition of issue date in
rule 19.12). For example, the issue date for a
pro rata entitlement issue must comply with
the applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
23 February 2017



Number
+
Class
8 Number and
+
class of all
+
securities quoted on ASX
(including the
+
securities in
section 2 if applicable)



196,011,282


Ordinary shares

Appendix 3B
New issue announcement


100256102/5396902.1
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 5


Number
+
Class
9 Number and
+
class of all
+
securities not quoted on ASX
(including the
+
securities in
section 2 if applicable)



815,540 Performance Rights


10 Dividend policy (in the case of a
trust, distribution policy) on the
increased capital (interests)
N/A


Part 2 - Pro rata issue

11 Is security holder approval
required?

N/A


12 Is the issue renounceable or non-
renounceable?
N/A


13 Ratio in which the
+
securities
will be offered
N/A


14
+
Class of
+
securities to which the
offer relates
N/A


15
+
Record date to determine
entitlements
N/A



16 Will holdings on different
registers (or subregisters) be
aggregated for calculating
entitlements?
N/A


17 Policy for deciding entitlements
in relation to fractions

N/A


18 Names of countries in which the
entity has security holders who
will not be sent new offer
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
N/A


19 Closing date for receipt of
acceptances or renunciations
N/A

Appendix 3B
New issue announcement


100256102/5396902.1
+ See chapter 19 for defined terms.
Appendix 3B Page 6 04/03/2013

20 Names of any underwriters


N/A


21 Amount of any underwriting fee
or commission
N/A


22 Names of any brokers to the
issue


N/A


23 Fee or commission payable to the
broker to the issue
N/A


24 Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders
N/A


25 If the issue is contingent on
security holders’ approval, the
date of the meeting
N/A


26 Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
N/A


27 If the entity has issued options,
and the terms entitle option
holders to participate on
exercise, the date on which
notices will be sent to option
holders
N/A


28 Date rights trading will begin (if
applicable)
N/A


29 Date rights trading will end (if
applicable)


N/A


30 How do security holders sell
their entitlements in full through
a broker?
N/A


31 How do security holders sell part
of their entitlements through a
broker and accept for the
balance?
N/A

Appendix 3B
New issue announcement


100256102/5396902.1
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 7

32 How do security holders dispose
of their entitlements (except by
sale through a broker)?
N/A


33
+
Issue date


N/A


Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities

34 Type of
+
securities
(tick one)

(a)

+
Securities described in Part 1


(b)

All other
+
securities
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid,
employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible
securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities


Tick to indicate you are providing the information or
documents


35

If the
+
securities are
+
equity securities, the names of the 20 largest holders of the
additional
+
securities, and the number and percentage of additional
+
securities
held by those holders


36

If the
+
securities are
+
equity securities, a distribution schedule of the additional
+
securities setting out the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over


37

A copy of any trust deed for the additional
+
securities

Appendix 3B
New issue announcement


100256102/5396902.1
+ See chapter 19 for defined terms.
Appendix 3B Page 8 04/03/2013

Entities that have ticked box 34(b)

38 Number of
+
securities for which
+
quotation is sought

N/A



39
+
Class of
+
securities for which
quotation is sought

N/A


40 Do the
+
securities rank equally in
all respects from the
+
issue date
with an existing
+
class of quoted
+
securities?

If the additional
+
securities do not
rank equally, please state:
 the date from which they do
 the extent to which they
participate for the next
dividend, (in the case of a
trust, distribution) or interest
payment
 the extent to which they do
not rank equally, other than in
relation to the next dividend,
distribution or interest
payment
N/A


41 Reason for request for quotation
now
Example: In the case of restricted securities, end
of restriction period

(if issued upon conversion of
another
+
security, clearly identify
that other
+
security)
N/A



Number
+
Class
42 Number and
+
class of all
+
securities quoted on ASX
(including the
+
securities in clause
38)



N/A N/A

Appendix 3B
New issue announcement


100256102/5396902.1
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 9


Quotation agreement

1
+
Quotation of our additional
+
securities is in ASX’s absolute discretion. ASX
may quote the
+
securities on any conditions it decides.

2 We warrant the following to ASX.

 The issue of the
+
securities to be quoted complies with the law and is
not for an illegal purpose.

 There is no reason why those
+
securities should not be granted
+
quotation.

 An offer of the
+
securities for sale within 12 months after their issue
will not require disclosure under section 707(3) or section 1012C(6) of
the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be
able to give this warranty

 Section 724 or section 1016E of the Corporations Act does not apply to
any applications received by us in relation to any
+
securities to be
quoted and that no-one has any right to return any
+
securities to be
quoted under sections 737, 738 or 1016F of the Corporations Act at the
time that we request that the
+
securities be quoted.

 If we are a trust, we warrant that no person has the right to return the
+
securities to be quoted under section 1019B of the Corporations Act at
the time that we request that the
+
securities be quoted.

3 We will indemnify ASX to the fullest extent permitted by law in respect of any
claim, action or expense arising from or connected with any breach of the
warranties in this agreement.

4 We give ASX the information and documents required by this form. If any
information or document is not available now, we will give it to ASX before
+
quotation of the
+
securities begins. We acknowledge that ASX is relying on
the information and documents. We warrant that they are (will be) true and
complete.


Sign here: ............................................................ Date: .........................
(Company secretary)


Print name: .........................................................

== == == == ==

Appendix 3B
New issue announcement


100256102/5396902.1
+ See chapter 19 for defined terms.
Appendix 3B Page 10 04/03/2013
Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for
eligible entities
Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
Insert number of fully paid
+
ordinary
securities on issue 12 months before the
+
issue date or date of agreement to issue
N/A
Add the following:
• Number of fully paid
+
ordinary securities
issued in that 12 month period under an
exception in rule 7.2
• Number of fully paid
+
ordinary securities
issued in that 12 month period with
shareholder approval
• Number of partly paid
+
ordinary
securities that became fully paid in that
12 month period
Note:
• Include only ordinary securities here –
other classes of equity securities cannot
be added
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
N/A
Subtract the number of fully paid
+
ordinary
securities cancelled during that 12 month
period
N/A
“A”
N/A

Appendix 3B
New issue announcement


100256102/5396902.1
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 11

Step 2: Calculate 15% of “A”
“B”
0.15
[Note: this value cannot be changed]
Multiply “A” by 0.15
N/A
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insert number of
+
equity securities issued
or agreed to be issued in that 12 month
period not counting those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule
7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
N/A
“C”
N/A
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15
Note: number must be same as shown in
Step 2
N/A
Subtract “C”
Note: number must be same as shown in
Step 3
N/A
Total [“A” x 0.15] – “C”
N/A
[Note: this is the remaining placement
capacity under rule 7.1]

Appendix 3B
New issue announcement


100256102/5396902.1
+ See chapter 19 for defined terms.
Appendix 3B Page 12 04/03/2013
Part 2

Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
“A”
Note: number must be same as shown in
Step 1 of Part 1
N/A
Step 2: Calculate 10% of “A”
“D”
0.10
Note: this value cannot be changed
Multiply “A” by 0.10
N/A
Step 3: Calculate “E”, the amount of placement capacity under rule
7.1A that has already been used
Insert number of
+
equity securities issued
or agreed to be issued in that 12 month
period under rule 7.1A
Notes:
• This applies to equity securities – not
just ordinary securities
• Include here – if applicable – the
securities the subject of the Appendix
3B to which this form is annexed
• Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
• It may be useful to set out issues of
securities on different dates as separate
line items
N/A
“E”
N/A

Appendix 3B
New issue announcement


100256102/5396902.1
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 13

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
“A” x 0.10
Note: number must be same as shown in
Step 2
N/A
Subtract “E”
Note: number must be same as shown in
Step 3
N/A
Total [“A” x 0.10] – “E”
N/A
Note: this is the remaining placement
capacity under rule 7.1A